[{"address1": "One Kendall Square", "address2": "3rd Floor Building 1400 West", "city": "Cambridge", "state": "MA", "zip": "02139", "country": "United States", "phone": "617 651 8867", "website": "https://www.camp4tx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops regulatory RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-CPS-001, which is in a Phase 1 clinical trial for the treatment of urea cycle disorders. The company also develops CMP-SYNGAP for the treatment of SYNGAP1-related disorders. Camp4 Therapeutics Corporation was formerly known as Marauder Therapeutics, Inc. and changed its name to Camp4 Therapeutics Corporation in March 2018. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.", "fullTimeEmployees": 55, "companyOfficers": [{"maxAge": 1, "name": "Mr. Joshua  Mandel-Brehm", "age": 41, "title": "CEO, President & Director", "yearBorn": 1983, "fiscalYear": 2024, "totalPay": 1889994, "exercisedValue": 0, "unexercisedValue": 193090}, {"maxAge": 1, "name": "Dr. Richard A. Young Ph.D.", "age": 70, "title": "Founder & Independent Director", "yearBorn": 1954, "fiscalYear": 2024, "totalPay": 143051, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kelly  Gold", "age": 47, "title": "Chief Financial Officer", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 905532, "exercisedValue": 0, "unexercisedValue": 33399}, {"maxAge": 1, "name": "Dr. Yuri  Maricich M.B.A., M.D.", "age": 43, "title": "Chief Medical Officer", "yearBorn": 1981, "fiscalYear": 2024, "totalPay": 822425, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Leonard I. Zon M.D.", "title": "Founder & Chairman of Scientific Advisory Board", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Caleb  Moore", "title": "Chief Business Operations Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Daniel  Tardiff Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Michelle  Gates", "title": "Senior VP & Chief People Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David  Bumcrot Ph.D.", "age": 62, "title": "Senior Vice President of Research", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 501933, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Alla  Sigova Ph.D.", "title": "Senior Vice President of Platform", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 5.92, "open": 5.92, "dayLow": 5.895, "dayHigh": 6.24, "regularMarketPreviousClose": 5.92, "regularMarketOpen": 5.92, "regularMarketDayLow": 5.895, "regularMarketDayHigh": 6.24, "payoutRatio": 0.0, "forwardPE": -6.516011, "volume": 93449, "regularMarketVolume": 93449, "averageVolume": 175206, "averageVolume10days": 492310, "averageDailyVolume10Day": 492310, "bid": 5.15, "ask": 8.6, "bidSize": 2, "askSize": 2, "marketCap": 309211584, "fiftyTwoWeekLow": 1.305, "fiftyTwoWeekHigh": 7.305, "allTimeHigh": 12.3, "allTimeLow": 1.305, "priceToSalesTrailing12Months": 81.32867, "fiftyDayAverage": 4.2906, "twoHundredDayAverage": 2.8059, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 210502560, "profitMargins": 0.0, "floatShares": 23474321, "sharesOutstanding": 51881134, "sharesShort": 453468, "sharesShortPriorMonth": 427457, "sharesShortPreviousMonthDate": 1763078400, "dateShortInterest": 1765756800, "sharesPercentSharesOut": 0.0097, "heldPercentInsiders": 0.14956, "heldPercentInstitutions": 0.61258, "shortRatio": 3.19, "shortPercentOfFloat": 0.0139999995, "impliedSharesOutstanding": 51881135, "bookValue": 1.251, "priceToBook": 4.7641883, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -53398000, "trailingEps": -10.85, "forwardEps": -0.91467, "enterpriseToRevenue": 55.366, "enterpriseToEbitda": -4.077, "52WeekChange": 0.09426987, "SandP52WeekChange": 0.17354333, "quoteType": "EQUITY", "currentPrice": 5.96, "targetHighPrice": 18.0, "targetLowPrice": 7.0, "targetMeanPrice": 10.4, "targetMedianPrice": 8.0, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 5, "totalCash": 75255000, "totalCashPerShare": 1.605, "ebitda": -51634000, "totalDebt": 6346000, "quickRatio": 9.522, "currentRatio": 9.833, "totalRevenue": 3802000, "debtToEquity": 10.817, "revenuePerShare": 0.179, "returnOnAssets": -0.6185, "returnOnEquity": -1.727, "grossProfits": -36039000, "freeCashflow": -31920624, "operatingCashflow": -47134000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -16.54969, "financialCurrency": "USD", "symbol": "CAMP", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "shortName": "CAMP4 THERAPEUTICS CORPORATION", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 0.675675, "regularMarketPrice": 5.96, "corporateActions": [], "postMarketTime": 1766796385, "regularMarketTime": 1766782801, "exchange": "NGM", "messageBoardId": "finmb_569025678", "exchangeTimezoneName": "America/New_York", "earningsTimestampStart": 1755028800, "earningsTimestampEnd": 1755028800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -10.85, "epsForward": -0.91467, "epsCurrentYear": -1.76607, "priceEpsCurrentYear": -3.3747246, "fiftyDayAverageChange": 1.6694002, "fiftyDayAverageChangePercent": 0.38908318, "twoHundredDayAverageChange": 3.1541, "twoHundredDayAverageChangePercent": 1.1240956, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1728653400000, "postMarketChangePercent": -5.780202, "postMarketPrice": 5.6155, "postMarketChange": -0.34450006, "regularMarketChange": 0.04, "regularMarketDayRange": "5.895 - 6.24", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 175206, "fiftyTwoWeekLowChange": 4.655, "fiftyTwoWeekLowChangePercent": 3.5670502, "fiftyTwoWeekRange": "1.305 - 7.305", "fiftyTwoWeekHighChange": -1.3449998, "fiftyTwoWeekHighChangePercent": -0.18412045, "fiftyTwoWeekChangePercent": 9.426987, "displayName": "Camp4 Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-12-27"}]